Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1983 2
1984 3
1985 6
1986 25
1987 15
1988 17
1989 17
1990 17
1991 27
1992 29
1993 28
1994 28
1995 30
1996 35
1997 46
1998 40
1999 37
2000 35
2001 27
2002 36
2003 36
2004 41
2005 29
2006 34
2007 46
2008 33
2009 33
2010 16
2011 23
2012 27
2013 25
2014 16
2015 19
2016 19
2017 18
2018 23
2019 13
2020 23
2021 28
2022 30
2023 16
2024 30
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,025 results

Results by year

Filters applied: . Clear all
Page 1
Terazosin.
[No authors listed] [No authors listed] 2024 Dec 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2024 Dec 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000707 Free Books & Documents. Review.
Because no information is available on the use of terazosin during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant....
Because no information is available on the use of terazosin during breastfeeding, an alternate drug may be preferred, especially whil …
[Terazosin].
Schäfers RF, Michel MC. Schäfers RF, et al. Dtsch Med Wochenschr. 1998 Apr 9;123(15):459-60. doi: 10.1055/s-0029-1233226. Dtsch Med Wochenschr. 1998. PMID: 9581161 Review. German. No abstract available.
Pharmacology of terazosin.
Kyncl JJ. Kyncl JJ. Am J Med. 1986 May 23;80(5B):12-9. doi: 10.1016/0002-9343(86)90846-6. Am J Med. 1986. PMID: 2872801
Terazosin is a quinazoline antihypertensive agent that is chemically similar to prazosin. ...The absorption of terazosin appeared to be slower than that of prazosin in rats. However, from eight to 16 hours after dosing, terazosin concentrations in plasma exce …
Terazosin is a quinazoline antihypertensive agent that is chemically similar to prazosin. ...The absorption of terazosin appea …
The efficacy and safety of terazosin for the treatment of symptomatic BPH.
Lepor H, Henry D, Laddu AR. Lepor H, et al. Prostate. 1991;18(4):345-55. doi: 10.1002/pros.2990180408. Prostate. 1991. PMID: 1711689 Review.
The dose of terazosin was titrated to maximal doses ranging between 5-20 mg. Only four of the 163 patients developed orthostatic hypotension. ...The cumulative improvement in the mean obstructive, irritative, and total symptom scores was 67%, 35%, and 54%, respectively (P …
The dose of terazosin was titrated to maximal doses ranging between 5-20 mg. Only four of the 163 patients developed orthostatic hypo …
Terazosin for hypertension.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 1987 Dec 18;29(755):112-3. Med Lett Drugs Ther. 1987. PMID: 2891021 Clinical Trial. No abstract available.
Terazosin. A pharmacoeconomic evaluation of its use in benign prostatic hyperplasia.
Plosker GL, Goa KL. Plosker GL, et al. Pharmacoeconomics. 1997 Feb;11(2):184-97. doi: 10.2165/00019053-199711020-00008. Pharmacoeconomics. 1997. PMID: 10165827 Review.
Approximately 5% of men with BPH discontinue terazosin because of adverse events. Results of an economic evaluation of terazosin, in which both clinical and economic data were collected prospectively in a randomised placebo-controlled study design, showed similar to …
Approximately 5% of men with BPH discontinue terazosin because of adverse events. Results of an economic evaluation of terazosin …
alpha-blocker treatment of urolithiasis.
Michel MC, de la Rosette JJ. Michel MC, et al. Eur Urol. 2006 Aug;50(2):213-4. doi: 10.1016/j.eururo.2006.02.047. Epub 2006 Mar 9. Eur Urol. 2006. PMID: 16545903 No abstract available.
Association of Terazosin, Doxazosin, or Alfuzosin Use and Risk of Dementia With Lewy Bodies in Men.
Hart A, Aldridge G, Zhang Q, Narayanan NS, Simmering JE. Hart A, et al. Neurology. 2024 Jul 23;103(2):e209570. doi: 10.1212/WNL.0000000000209570. Epub 2024 Jun 19. Neurology. 2024. PMID: 38896813
BACKGROUND AND OBJECTIVES: Terazosin, doxazosin, and alfuzosin (Tz/Dz/Az) are alpha-1 adrenergic receptor antagonists that also bind to and activate a key adenosine triphosphate (ATP)-producing enzyme in glycolysis. ...
BACKGROUND AND OBJECTIVES: Terazosin, doxazosin, and alfuzosin (Tz/Dz/Az) are alpha-1 adrenergic receptor antagonists that also bind …
Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in benign prostatic hyperplasia.
Wilde MI, Fitton A, Sorkin EM. Wilde MI, et al. Drugs Aging. 1993 May-Jun;3(3):258-77. doi: 10.2165/00002512-199303030-00007. Drugs Aging. 1993. PMID: 7686794 Review.
The efficacy of terazosin is reflected in increases in peak urinary flow rate, and reductions in obstructive and irritative symptom scores compared with placebo, and reductions in residual urinary volume from baseline. ...Terazosin also shows promise as a nonsurgica …
The efficacy of terazosin is reflected in increases in peak urinary flow rate, and reductions in obstructive and irritative symptom s …
The safety and efficacy of terazosin in the treatment of essential hypertension in blacks.
Saunders E. Saunders E. Am Heart J. 1991 Sep;122(3 Pt 2):936-42. doi: 10.1016/0002-8703(91)90815-y. Am Heart J. 1991. PMID: 1678925 Review.
Changes (mean +/- SE) in sitting diastolic blood pressure from baseline were -8.1 +/- 1.4 mm Hg for terazosin and -5.0 +/- 1.5 mm Hg for propranolol. Terazosin (5 mg) combined with methyclothiazide (2.5 to 5 mg) produced a significantly greater (p less than 0.01) an …
Changes (mean +/- SE) in sitting diastolic blood pressure from baseline were -8.1 +/- 1.4 mm Hg for terazosin and -5.0 +/- 1.5 mm Hg …
1,025 results